Evidence map›Paper›PMID 37377752›Full record

ArticleCancer research communications2023

Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring

Keiichi Ohshima, Takeshi Nagashima, Keiichi Fujiya, Keiichi Hatakeyama, Yuko Watanabe, Kimiko Morimoto, Fukumi Kamada, Yuji Shimoda, Sumiko Ohnami, Akane Naruoka and 13 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer research communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Molecular Mechanisms and Clinical Implications ofCurrent issues in molecular biology · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 1 institution in 1 country.

Keiichi OhshimaMedical Genetics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID 0000-0002-2882-7566
Takeshi NagashimaCancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID 0000-0002-7261-9908
Keiichi FujiyaDivision of Gastric Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.ORCID 0000-0002-5245-2493
Keiichi HatakeyamaCancer Multiomics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID 0000-0001-6000-5899
Yuko WatanabeMedical Genetics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID 0000-0002-9327-1832
Kimiko MorimotoMedical Genetics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID 0009-0005-8021-1071
Fukumi KamadaCancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID 0009-0003-9065-9668
Yuji ShimodaCancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID 0009-0002-5613-0886
Sumiko OhnamiCancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID 0000-0002-5776-8104
Akane NaruokaDrug Discovery and Development Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID 0000-0002-6401-0318
Masakuni SerizawaDrug Discovery and Development Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID 0009-0009-6383-8402
Shumpei OhnamiCancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID 0000-0001-7840-3537
Hirotsugu KenmotsuDivision of Genetic Medicine Promotion, Shizuoka Cancer Center Hospital, Shizuoka, Japan.ORCID 0000-0003-0590-9259
Akio ShiomiDivision of Colon and Rectal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.ORCID 0000-0001-5657-8686
Yasuhiro TsubosaDivision of Esophageal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.ORCID 0000-0003-1630-1265
Etsuro BandoDivision of Gastric Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.ORCID 0000-0002-3072-4910
Teiichi SugiuraDivision of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.ORCID 0000-0001-7163-4084
Takashi SuginoDivision of Pathology, Shizuoka Cancer Center Hospital, Shizuoka, Japan.ORCID 0000-0002-0205-0525
Masanori TerashimaDivision of Gastric Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.ORCID 0000-0002-2967-8267
Katsuhiko UesakaDivision of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.ORCID 0000-0002-9983-1730
Kenichi UrakamiCancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID 0000-0002-4751-0978
Yasuto AkiyamaImmunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID 0000-0003-3813-7726
Ken YamaguchiShizuoka Cancer Center Hospital and Research Institute, Shizuoka, Japan.ORCID 0000-0002-9893-7218
Shizuoka Cancer Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal stromal tumors (GIST) with Significance: We present genomic and epigenomic insights into the malignant progression of GISTs with

Indexed as

Gastrointestinal Stromal TumorsDNA, IntergenicEpigenomicsExonsGenomic InstabilityHumansProto-Oncogene Proteins c-kitSequence DeletionDNA, IntergenicKIT protein, humanProto-Oncogene Proteins c-kit

Identifiers

PMID37377752
PMCPMC10124575
OpenAlexW4353065277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.